Patricia Carr - 14 Aug 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role: SVP, Chief Accounting Officer
Signature: By: /s/Adam Guttmann as attorney in fact For: Patricia Carr
Issuer symbol: JAZZ
Transactions as of: 14 Aug 2023
Net transactions value: -$21,829
Form type: 4
Filing time: 15 Aug 2023, 17:43:07 UTC
Previous filing: 09 Jun 2023
Next filing: 31 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAZZ	Ordinary Shares	Sale	$21,829	-158	-2.5%	$138.16	6,128	14 Aug 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2	Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.77 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Content

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.77 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.